Navigation Links
ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
Date:2/15/2011

MENLO PARK, Calif., Feb. 15, 2011 /PRNewswire/ -- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Octet RED96 System, as well as its new Dip and Read Protein L Biosensor for use on the company's Octet platform. The product introductions further widen the scope and utility of the company's flagship instrumentation system, which provides real-time, label-free analysis of biomolecular interactions, with unprecedented ease of use and cost-efficiency.

The Octet RED96 system can rapidly measure protein and other biomolecule concentrations, as well as determine kinetics, affinity and specificity of protein-protein and protein-small molecule interactions. It extends the capabilities of the company's premier Octet RED platform by featuring biosensor re-racking, which enables more efficient workflow, reduced amounts of capture molecule use and lower assay-running costs.

"Our new Octet RED96 system enables life science researchers to perform analyses that have traditionally been conducted with SPR, HPLC, ELISA and other single-purpose microfluidics instruments, now with unmatched performance and cost-efficiency," said Christopher Silva, ForteBio's vice president of marketing. "For example, with concentration analysis, the system's 8-channel simultaneous read-out quantitates 96 samples in 30 minutes and its re-racking feature extends the number of tests that can be performed with a single biosensor."

ForteBio's new Dip and Read Protein L biosensor enables rapid and direct quantification of a broad set of kappa light chain containing immunoglobulins, including Fab fragments and single-chain variable fragments otherwise known as ScFv.

"Protein L binds with high affinity to several more species and isotypes than both Protein A and Protein G, giving it broader potential applications," said Mr. Silva. "With ForteBio's new Protein L biosensor, which can be regenerated and reused, scientists can now obtain highly sensitive quantitation results in real time, in a cost-effective and easy-to-use manner. Further, our bioprocess customers will now be able to run a suite of assays in a multiplexed panel format using our Protein A, Protein G and Protein L biosensors."

ForteBio's Octet platform is based on the company's proprietary BioLayer Interferometry (BLI) technology, which uses optical biosensors to measure multiple interactions in parallel, without the use of detection agents. The Octet platform consists of 8- and 16-channel instruments that accommodate 96- and 384-well assay formats. All Octet biosensors are designed to simplify kinetic characterization and quantitation by eliminating throughput and time-to-result limitations of traditional SPR-based assays and ELISA. The Octet biosensors are disposable, configured in a standard microplate format and are coated with a proprietary biocompatible matrix that is uniform, non-denaturing and has minimal non-specific binding.

ABOUT FORTEBIO, INC.

ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com.


'/>"/>
SOURCE ForteBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
2. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
3. Mylan Launches First Generic Version of Vfend® Tablets
4. PARI Respiratory Launches New Website
5. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
6. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
7. FDA Launches Medical Device Innovation Initiative
8. UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado
9. Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter
10. SkinMedica Launches Redness Relief CalmPlex™
11. Valeant Launches Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
Breaking Medicine News(10 mins):